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40-word summary:  
Indonesia is aiming for malaria elimination by 2030. A parasitological survey of 3,731 individuals in 
North Sumatera province identified 1,169 parasitaemic individuals by PCR. Highly specific 
amplification of sicavar genes was used to identify Plasmodium knowlesi infection in 377 people.  
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ABSTRACT  
Background 
As Indonesia works towards the goal of malaria elimination, information is lacking on malaria 
epidemiology from some western provinces. As a basis for studies of antimalarial efficacy, we set out 
to survey parasite carriage in three communities in North Sumatera Province. 
 Methods  
A combination of active and passive detection of infection was carried out among communities in 
Batubara, Langkat and South Nias regencies. Finger-prick blood samples from consenting individuals 
of all ages provided blood films for microscopic examination and blood spots on filter paper. 
Plasmodium species were identified by nested PCR of rRNA genes, and a novel assay which amplifies 
a conserved sequence specific for the sicavar gene family of P. knowlesi. 
Results  
614 of 3,731 participants (16.5%) were positive for malaria parasites by microscopy. PCR detected 
parasite DNA in samples from 1,169 individuals (31.3%). In total, 377 participants (11.8%) harboured 
P. knowlesi. Also present were P. vivax (14.3%), P. falciparum (10.5%) and P. malariae (3.4%).    
Conclusions  
Amplification of sicavar is a specific and sensitive test for the presence of P. knowlesi DNA in 
humans. Subpatent and asymptomatic multi-species parasitaemia is relatively common in North 
Sumatera, and so PCR-based surveillance is required to support control and elimination activities.  
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INTRODUCTION  
Malaria remains widespread across the South East Asian region. In Indonesia, 2 million cases 
of malaria are reported each year. Plasmodium falciparum and P. vivax are reported to be the two 
major causes of malaria [1]. Among the other species contributing to human infections, P. malariae 
malaria may require hospitalisation in the eastern province of Papua [2], but is not frequently 
encountered in western Indonesia. P. knowlesi is a parasite of long-tailed and pig-tailed macaques, 
also known to infect humans. The morphological features in the blood stage are similar to P. 
falciparum and P. malariae, which in routine practice has led to frequent misdiagnosis [3-5]. High P. 
knowlesi parasitaemia occurs in some individuals, and has been reported to cause fatal disease [6]. 
Despite this, a proportion of P. knowlesi infections are asymptomatic and submicroscopic across all 
age groups [7].  A small number of human cases of P. knowlesi have been documented in the 
province of Kalimantan, Indonesian Borneo [8] and in Aceh province [5] but this species has not yet 
emerged as a major cause of human malaria and is not considered in Indonesian Government 
guidelines.   
The Ministry of Health of Indonesia has implemented malaria control, aiming for elimination 
by 2030. Malaria surveillance relies on passive case detection by microscopic examination and rapid 
diagnostic tests (RDT) at primary health care centres [9]. These tests are sufficient to detect clinical 
malaria infection caused by the two major species in Indonesia, P. falciparum and P. vivax [10]. 
However, identification of less common species, particularly at low density parasitaemia, is more 
difficult and can lead to under-diagnosis [11]. Modelling of data from low endemicity areas predicts 
that submicroscopic parasites may contribute 70 to 80% of all malaria infections [12], and in vivo 
studies demonstrate that these contribute to ongoing malaria transmission [13]. Hence, the use of 
routine microscopy and RDT in malaria surveillance fails to detect a substantial proportion of the 
human reservoir of infection and so may compromise malaria elimination strategies.  One solution is 
to deploy molecular assays for parasite detection, as these can provide excellent sensitivity and 
specificity [14-17].  
In preparation for a study of antimalarial drug efficacy in vivo, we performed intensive 
malaria screening in three Regencies of the Province of North Sumatera, western Indonesia. In 
addition to microscopy, established PCR assays were deployed [18]. However, these tests have 
limitations for the identification of P. knowlesi infection, as the target region of the 18S ribosomal 
RNA can cross-react with P. vivax [19]. Therefore, we developed a sensitive and highly P. knowlesi-
specific nested-PCR assay to ensure reliable determination of all Plasmodium species, including 
submicroscopic infection, in our study areas.    
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METHODS AND MATERIALS  
Study sites  
A parasitological survey was conducted between January and June 2015 among people 
attending out-patient clinics temporarily established in more than 80 localities across three selected 
regencies in North Sumatera province, Indonesia: Batubara regency, Langkat regency and South Nias 
regency (Figure 1). North Sumatera has a total area of 71,680.68 km2 with a population of 
13,215,401. The province is subject to stable low malaria transmission, and is currently planning for 
elimination by 2020. The three regencies were selected based on published malaria endemicity data 
[20]. Batubara Regency, situated on the east coast facing peninsular Malaysia, comprises semi-
forested and plantation areas. Langkat Regency is a forested highland area (altitude 105-530m 
above sea level), and South Nias Regency is a cluster of islands in the Indian Ocean. Each regency is 
served by a district hospital and peripheral health clinics, however some rural villages in the study 
areas have very limited access to these services.   
 
Ethics approval 
The study was approved by the ethics committee of the University of Sumatera Utara, 
Indonesia (ID# 401/KOMET/FK USU/2014), and the ethics committee of the London School of 
Hygiene and Tropical Medicine, United Kingdom (ID# 8504‑01).  
 
Sampling    
Sampling strategies differed among the three sites, due to contrasting geography and 
inconsistencies in access to health facilities. In Batubara, most communities had good access to a 
health clinic, which was open to patients from 08:00 to 12:00, 6 days per week. We established a 24-
hour, 7-day clinic for an 8-week period of screening, following intensive health promotion and 
education on malaria, and sensitisation as to our study objectives. This sensitisation was facilitated 
by local leaders and carried out at the level of the whole community, but clinic attendance was 
entirely voluntary. Thus sampling was not designed to reach the whole community. Local health 
clinics were also asked to refer patients diagnosed with malaria to our team. Langkat is a forested 
area with isolated villages that have poor access to health facilities; we therefore adopted a village-
by-village approach in which a sensitisation meeting was followed by 2-3 days of screening, before 
the team moved to another village. The 31 communities we sampled in South Nias were spread 
across several islands, and sea journeys were required to move our team and the samples between 
each village and our study clinic / diagnostic lab which was temporarily set up in a central location on 
Tello Island.  
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Malaria testing was done on three groups of people. Firstly, patients with fever (axillary 
temperature > 37.5 ⁰C) or history of fever in the preceding 48 hours who presented at the health 
clinics were tested for malaria. Tests were also offered to healthy individuals who, following our 
community sensitisation activity, came for a voluntary malaria check. This second group includes 
children who volunteered during school sensitisation visits (Batubara and South Nias only). Thirdly, 
household members of any individuals slide-positive for malaria parasites were subsequently visited 
and also offered malaria testing. Finger-prick blood samples were taken from all participants for 
thick and thin blood films for microscopy examination (single read), and also spotted onto filter 
papers (3MM Whatman) for molecular analysis. Participants confirmed as malaria-positive by 
microscopy were clinically assessed and treated according to national guidelines, regardless of 
symptoms.  
 
Laboratory Procedures 
DNA extraction 
Parasite DNA was extracted from filter papers using the Chelex method [21, 22].  
Parasite species identification by rRNA gene amplification  
A conventional nested PCR assay targeting the genes encoding the Plasmodium 18S ribosomal RNA 
was performed on all samples for species determination and detection of submicroscopic infections 
[3, 18]. Positive controls for P. falciparum, P. vivax, P. malariae, P. ovale spp. and P. knowlesi were 
included in all nested-PCR assays. 
 
Development and validation of a novel highly-specific P. knowlesi PCR assay 
To overcome the cross-reactivity between P. knowlesi and P. vivax which occurs in the rRNA gene 
PCR assays, we developed a hemi-nested PCR assay based on a conserved region of the amino-
terminal exon of the 50-70 members of the gene family encoding P. knowlesi-specific variant antigen 
family SICAvar [23]. The primers used were as follows: SICAf1, 5’-GGTCCTCTTGGTAAAGGAGG-3’and 
SICAr1, 5’- CCCTTTTTGACATTCGTCC-3’ for the first amplification and SICAf2, 5’-
CTTGGTAAAGGAGGACCACG-3’ and SICAr1 for second amplification, generating a final amplicon of 
228 – 249bp, encoding 76-83 amino acids. This sequence occurs in both Type 1 and Type 2 sicavar 
genes (Supplementary Table 1 in [23]). For the first round of amplification, 5 µL of DNA template was 
used in a total of 25 µL volume, and 0.2 µL of this product was template for the 25 µL reaction 
mixture of the hemi-nested amplification round. Amplifications were performed under the following 
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conditions: 94 ⁰C for 3 min, then 30 cycles of 94 ⁰C for 30 secs, 55 ⁰C for 30 secs, and 65 ⁰C for 1 min, 
with extension at 65 ⁰C for 5 min. This assay was tested against control DNA from all human malaria 
parasites (P. falciparum, P. vivax, P. malariae, P. ovale curtisi and P. ovale wallikeri), simian malaria 
parasites (P. knowlesi, P. inui, P. cynomolgi, P. coatneyi and P. fieldi), clinical P. knowlesi isolates 
obtained from Kapit of Malaysian Borneo and human DNA from malaria-free individuals to assess 
specificity. To determine the limit of detection of the assay, P. knowlesi culture of known 
parasitaemia (kindly provided by F. Mohring) was serially diluted in whole human blood, spotted on 
filter paper and DNA extracted by in a QIASymphony automated DNA extraction system. All field 
isolates were tested for P. knowlesi infection using this novel PCR assay. Sicavar amplicons from a 
subset of samples were verified by direct sequencing using BigDye Terminator v3.1 cycle sequencing 
kits and analysis on an ABI 3730 Sequencer (Applied Biosystems). Results were aligned and 
compared to P. knowlesi strain H reference genome using Geneious v.8.0.5 and BLAST.   
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RESULTS  
Validation of SICAvar assay for P. knowlesi-specific identification 
The novel SICAvar gene assay was validated against DNA from a range of Plasmodium 
species DNA, and from in vitro cultured P. knowlesi. The test was found to be specific, as the primers 
did not generate bands from the DNA of any of the Plasmodium species tested other than P. 
knowlesi (Figure 2). The sicavar-targeted primers detected 377 P. knowlesi infections, suggesting 
significantly higher sensitivity than the rRNA assay, which identified only 76 P. knowlesi–infected 
individuals (Table 1). Further, comparison of the results showed that only 10 cases (2.3%) 
demonstrated a positive test result in both assays. The finding that 66 individuals were seen as P. 
knowlesi-positive by rRNA nested PCR alone suggests the test cross-reacts with P. vivax DNA in the 
absence of P. knowlesi under the conditions used in this study. As we did not deploy a “tie-breaker” 
test for P. vivax, we cannot say for certain whether the P. vivax rRNA gene primers also cross-react 
with P. knowlesi DNA. We did find that 18 individuals were positive for both P. vivax and P. knowlesi 
rRNA amplicons in the nested PCR. Given this ambiguity, and the fact we were not able to repeat 
test the sample set, we proceeded with analysis taking the sicavar assay result as definitive for P. 
knowlesi.  Nearly half of all sicavar-positive P. knowlesi infections were also rRNA amplicon-positive 
for at least one other species, P. vivax being the most common co-infection (Table 1).  The limit of 
detection of the assay, as performed on dried filter paper blood samples, was estimated as 0.1 
parasites per L of whole blood (data not shown).   
As further confirmation of our results, seven P. knowlesi isolates detected by SICAvar were 
PCR-amplified and the products directly sequenced. The sequences exhibited high variability, as 
expected for variant antigens, even in this most conserved exon (Figure 3). Interestingly, two of the 
seven sequences obtained harboured an insert encoding an additional 7 amino acids. These two 
forms were used to probe the current P. knowlesi reference genome 
(http://www.sanger.ac.uk/resources/downloads/protozoa/plasmodium-knowlesi.html ) and both 
queries identified a number of distinct sequences in the reference genome (Suppl. Table 1). 
Following this successful validation of the SICAvar PCR assay, we were able to deduce robust 
estimates of the contribution of each species to malaria infections in each of our three sites. Either 
or both P. falciparum and P. vivax were the most abundant in both Langkat and South Nias, as 
expected. However in Batubara regency, P. knowlesi (39.7%) was more abundant than P. vivax 
(35.1%) among our tested participants (Figure 4). Of patients reporting fever symptoms in the 
previous 72 hours, 22 were carrying P. knowlesi mono-infection by PCR, with a further 47 having P. 
knowlesi double infections with P. vivax (n=20), P. falciparum (n=19) or P. malariae (n=2), or various 
combinations of triple species infection. 
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Parasite carriage 
A total of 3731 individuals from Batubara (n = 1270), Langkat (n = 544) and South Nias (n = 
1917) were included in the malaria screening (Supplementary Table 2). At each regency, 117 (9.2%), 
98 (18.0%) and 397 (21.3%) individuals were positive for Plasmodium infections by microscopy. 
Three species (P. falciparum, P. vivax and P. malariae) were identified. A considerable number of 
participants with malaria-positive slides were negative by PCR subsequently performed on stored 
blood spots. Thus the total number of patent infections confirmed by both microscopy and PCR 
decreased to 93 (8.1%), 74 (13.6%) and 169 (9.1%), respectively, indicating poor specificity of 
microscopy in South Nias in particular. Conversely, a substantial number of submicroscopic 
infections were identified by PCR alone, with a PCR-confirmed parasite carriage in 25.2%, 33.5% and 
34.8% of tested individuals, respectively, in the three sites (Table 2). All Plasmodium species with the 
exception of P. ovale spp. were detected among our samples by a combination of the rRNA gene and 
SICAvar PCR assays.  
 
Carriage of submicroscopic infections 
PCR analysis revealed that the majority of the 1169 infected individuals (71.3%) harboured 
submicroscopic parasites (Table 2). Among these submicroscopic infections, 77.7% (647/833) were 
single-species infections predominated by P. vivax (227) and P. knowlesi (220).  Submicroscopic 
infections of any species were more often found in older individuals, the mean age in this group 
being 23.0 years, (95% CI 21.7 - 24.3 years). The mean age of individuals with patent infections was 
significantly lower at 18.0 years (95% CI 16.2 - 19.7; P < 0.001, 2-sided t-test) (Table 3). 
Submicroscopic carriage was more often observed in Batubara regency (OR 1.67, 95% CI: 1.14 – 
2.45) and South Nias regency (OR 2.02, 95% CI: 1.43-2.85) compared to Langkat regency. However, 
individuals with multi-species infections were not significantly older than those infected with a single 
species (P = 0.66, 2-sided t-test).   
  
Ac
ce
pt
ed
 M
an
us
cr
ipt
DISCUSSION  
In this study, a total of 3,731 febrile and non-febrile residents of three regencies in North Sumatera 
province were screened for malaria infection by both microscopy and PCR detection of parasite 
DNA. Microscopy identified 612 infected participants, whereas PCR identified 1,169 individuals 
harbouring at least one of the four Plasmodium species identified: P. falciparum, P. knowlesi, P. 
malariae and P. vivax.  Using a novel assay developed for this study which detects a conserved motif 
in the multi-copy sicavar gene family, we found that P. knowlesi was present in 377 individuals 
(10.1%), including both patent and sub-patent infections. P. vivax and P. falciparum were both 
frequently detected, occurring in 11.3% and 8.2% of all individuals tested.  
Although P. knowlesi infection has been widely recorded in Southeast Asia, only a  handful of 
confirmed cases have been from Indonesia, from Kalimantan, eastern Borneo [8, 24], and more 
recently 20 cases from Aceh province, on the north-west extremity of Sumatera [5]. This latter study 
of 1532 individuals used a combination of passive and reactive case detection to identify a total of 
20 P. knowlesi infections, 15 P. vivax and 8 P. falciparum infections, almost all of which were 
symptomatic. This contrasts with our findings of more frequent parasite carriage, and a significant 
proportion of subpatent and asymptomatic infections. Malaria transmission intensity is much lower 
in Aceh than in North Sumatera, and this neighbouring province is closer to elimination of the 
disease. North Sumatera’s natural forests have been affected by deforestation in the last few years. 
In rural districts, people may live in close proximity to semi-forested, forested or plantation areas, 
with a high likelihood of forest exposure, but may not have adequate access to health facilities and 
antimalarial medication. In the Aceh study, the more frequent occurrence of symptoms in people 
with knowlesi malaria reflects observations in Malaysian Borneo where, as in Aceh, other 
Plasmodium species have decreased in prevalence over the past decade [4, 25]. In North Sumatera, 
as our data show, P. falciparum and P. vivax remain common and it may be that acquired immunity 
to these human parasites protects individuals subsequently infected with P. knowlesi, although 
asymptomatic infections have also been reported in Sabah [7].   
Our novel PCR assay identified an unexpectedly large number of P. knowlesi infections, and 
so we made some effort to validate its sensitivity and specificity (Figure 2). Schizont-infected cell 
agglutination (SICA) variant genes encode an antigen family unique to P. knowlesi, estimated to 
number over a hundred members, including both multi-exon and truncated forms randomly 
distributed across all 14 chromosomes [23]. SICAvar proteins undergo antigenic variation in the 
course of a single infection [26, 27], and are likely to play a key role in maintaining chronic 
parasitaemia in semi-immune hosts. Sequencing of a handful of sicavar amplicons from our samples 
confirmed nucleotide diversity in our short target sequence, double peaking indicative of multiple 
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loci being amplified in some cases, and distinguished a variant form with a 7 amino acid insert 
(Figure 3). Probing the P. knowlesi reference genome with these two forms generated many hits 
with both length variants, including both Type 1 and Type 2 loci (Suppl. Table 1). These findings 
suggest our assay is performing as hoped and is a useful tool for identifying P. knowlesi infections 
among complex mixtures of Plasmodium species.  
The national malaria control programme focuses on case management through passive 
surveillance at primary health centres, deploying microscopy or RDT to detect malaria cases to be 
treated [9]. In our study, microscopy identified many Plasmodium spp. infections, but lacked 
accuracy in distinguishing among the four species present, as previously reported in Malaysia [28]. 
Although personnel differed between sites, identification of the less common species was 
problematic in all sites. P. malariae was only detected in 1 case and P. knowlesi was left 
unrecognised. In South Nias, microscopy results showed poor specificity (Supplementary Table 2), 
leading to a number of false positives, whereas specificity was good at the other two sites. RDT have 
limitations for detection of P. knowlesi because only P. falciparum and P. vivax parasite LDH 
monoclonal antibodies are included [11]. Most importantly, almost half of the infections detected by 
PCR were not identified by either of the conventional tests.  Therefore, although RDT and 
microscopy remain satisfactory for diagnosis of symptomatic falciparum and vivax malaria requiring 
treatment, these are not adequate tools for malaria elimination and control activities, as sub-
microscopic Plasmodium carriage is associated with subsequent transmission to mosquitoes [13].    
On the other hand, molecular tests are highly sensitive and specific, provide the capacity to 
detect low density infections missed by microscopy or RDT, and are well established for detection of 
human malaria infections [11, 29]. To overcome cross-amplification of P. vivax isolates with 
ribosomal gene PCR assays [3, 19], we have recently described a PCR-sequencing approach to detect 
P. knowlesi cytb DNA, which also provided satisfactory sensitivity [30]. However, our sicavar target 
assay provides greater sensitivity for P. knowlesi identification in our hands, and was effective in 
detecting submicroscopic parasites. This is a species-specific test, as the sicavar gene family is 
unique to P. knowlesi (Fig. 2). As a result of this improved specificity and sensitivity, we can 
confidently report moderate numbers of P. knowlesi co-infections with P. vivax in the present study.     
Despite the aim to achieve malaria elimination by 2020 in Sumatera, our study 
demonstrated that a substantial number of individuals in our study areas carried parasites. P. 
falciparum contributed one-fifth of infections, while P. vivax was slightly more often seen. 
Interestingly, our findings also demonstrate that P. knowlesi carriage is not uncommon. Many P. 
knowlesi-infected individuals harboured additional Plasmodium species (Table 1), in contrast to 
areas in Malaysian Borneo where P. vivax and P. falciparum are now very scarce [4, 7]. Multiple-
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species infections in our study were equally distributed across all age groups with both females and 
males exposed to a similar risk of infection (data not shown), whereas sub-microscopic infections 
were more common in older individuals (Table 2), suggesting a role for acquired immunity [31]. The 
observation of asymptomatic P. knowlesi infections in our study is consistent with recent findings in 
Malaysia [7], but does not necessarily support the occurrence of human-mosquito transmission of P. 
knowlesi. Macaques were present in all sites, and the communities shared established risk factors 
for malaria transmission by forest-dwelling Anopheles thought to be the vector of P. knowlesi. These 
data may suggest that acquired immunity permits sustainable chronic infections with this simian 
parasite. Cross-protection among the four human Plasmodium species may maintain overall parasite 
density at low levels [31], and this could also plausibly apply to P. knowlesi, particularly in settings 
where the closely related P. vivax is present. One weakness of our study is the lack of a systematic 
sampling procedure which may have introduced bias; as we had not previously worked in these 
three regions, methodology was adapted for each site to reflect the facilities available and particular 
local challenges. For South Nias, these included frequent sea journeys in small boats. Future studies 
could deploy a more systematic approach and collect sufficient data to better understand and 
characterise asymptomatic infections, now that community contacts have been established and 
baseline information is available.  
Our study demonstrated the importance of submicroscopic infections of four Plasmodium 
species, including P. knowlesi, to malaria transmission in North Sumatera.  There is an urgent need 
for the national malaria programme to include in malaria guidelines the recommendation that 
microscopists are trained to identify P. knowlesi infection in Indonesian clinics. Molecular detection 
of infection is also needed, to strengthen control and elimination programmes by accurately defining 
the true extent of the malaria reservoir, so as to achieve the current goal of elimination [32].   
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Figure Legends  
Figure 1.  Map of North Sumatera province, Indonesia.  
  The three studied regencies (Batubara regency, Langkat regency, South Nias 
regency) are indicated.  
 
 
 
Figure 2.  Validation of P. knowlesi primers targeting sicavar against human and simian 
malaria parasites reported from SE Asia.  
 Control DNA of human malaria species were from imported cases in the UK 
(courtesy of the PHE Malaria Reference Laboratory), 2 different isolates each for P. 
falciparum, P. vivax and P. malariae are shown. 
 Genus-specific primers for the cytochrome B gene (cytb) were used to confirm 
presence of detectable Plasmodium DNA in each sample, indicated by + symbol.   
 
 
 
Figure 3.  Sequence alignment of representative 120 and 141 nucleotide sequences of 
SICAvar amplicons from the peripheral blood DNA of four participants from 
Batubara (BB), and two each from Langkat (LK) and South Nias (NS).  
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 Amplicons were produced by hemi-nested PCR as described in Materials and 
Methods. Sample order is determined by the alignment. Representative 
amplification products were chosen for this sample, and sequenced directly using 
amplification primers to prime forward and reverse sequencing reactions. 
Sequences shown were confirmed in both directions. Two loci from the P. knowlesi 
strain H reference genome (PKNH_0932000, Type I SICAvar, chrom 9, centrally 
located; PKNH_0118500, Type II SICAvar, chrom 1, sub-telomeric) are shown for 
comparison. Double-peaking was seen in some samples – only the peak with 
highest amplitude was read for this analysis. 
 
 
 
Figure 4.  Proportion of Plasmodium species and multiplicity of infections in each regency. 
 Denominators for each site (total number of individuals tested) are given under 
each regency name. The number of parasite-positive individuals is shown at top-
left of each bar graph. Coloured bars denote species, grey bars denote proportion 
of mixed-species infections identified in each site. Pf = P. falciparum, Pv = P. vivax, 
Pm = P. malariae, Pk = P. knowlesi.  
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Table 1. Comparison of two PCR assays for P. knowlesi cases detection 
 
18 ssu rRNA assay SICAvar assay 
Total P. knowlesi cases 76 377 
P. knowlesi mono infection 42 (55.3%) 215 (57.0%) 
P. knowlesi + P. vivax 16 (21.1%) 65 (17.2%) 
P. knowlesi + other   
 Plasmodium spp. infections 
18 (23.7%) 97 (25.7%) 
Cases positive  by both assays 10  
Total P. knowlesi cases  detected with 
any assay 
443 
P. knowlesi mono infection 254/443 (57.34%) 
 
Relative frequencies (percentages) read vertically.  
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Table 2. Sub-microscopic infections in 1169 Plasmodium spp. PCR-positive participants 
 
 All PCR Positive (%) 
PCR positive 
microscopy negative 
   
PCR-positive 1169 (31.33) 833 (71.26) 
P. falciparum 247 (6.62) 165 (14.11) 
P. vivax 335 (8.97) 227 (19.41) 
P. malariae 40 (1.07) 35 (2.99) 
P. knowlesi 254 (6.80) 220 (18.81) 
Mixed infections 293 (7.85) 186 (15.91) 
   
Species multiplicity by PCR   
1 876 (74.94) 647 (77.67) 
2 256 (21.90) 163 (19.57) 
3 35 (2.99) 21 (2.52) 
4 2 (0.17) 2 (0.24) 
   
PCR-positivity by regency   
Batubara 320/1270 (25.19) 227/320 (70.93) 
Langkat 182/544 (33.45) 108/182 (59.34) 
South Nias 667/1917 (34.79) 498/667 (74.66) 
 
 
Frequencies are shown together with relative frequency expressed as a percentage (in brackets) of 
the total number of participants (N=3731), all PCR positives (n=1169) or all sub-microscopic 
infections (n=833).   
Top row percentages read horizontally; the percentages for other indented categories read vertically 
within the appropriate sub-group, apart from the regency-specific data (denominators as shown). 
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Table 3. Age and gender of participants PCR-positive for Plasmodium spp.  
 
 PCR positive (%) 
Age  
P. falciparum  
          <5 years 24 (9.72) 
5-14 years 91 (36.84) 
>15 years 132 (53.44) 
P. vivax  
          <5 years 41 (12.24) 
5-14 years 143 (42.69) 
>15 years 151 (45.07) 
P. malariae  
          <5 years 4 (10.00) 
5-14 years 18 (45.00) 
>15 years 18 (45.00) 
P. knowlesi  
          <5 years 28 (11.02) 
5-14 years 96 (37.80) 
>15 years 130 (51.18) 
Parasite carriage among 
females 
608 (52.01) 
P. falciparum 137 (55.47) 
P. vivax 171 (51.04) 
P. malariae 15 (37.50) 
P. knowlesi 129 (50.79) 
 
 
Frequencies are shown together with relative frequency expressed as a percentage (in brackets) of 
the total number of participants. 
Top row percentages read horizontally; the percentages for all other indented categories read 
vertically. 
Age and sex data are presented for single species infection only. 
 
 
